Increasing threat of Gram-positive bacterial infections in the intensive care unit setting

Critical Care Medicine
J E McGowan

Abstract

The effects of resistance are being noted on an increasing scale in the intensive care unit (ICU). Around the world, new epidemiologic patterns of ICU occurrence are being observed for Gram-positive multidrug-resistant organisms. Current problems include the appearance of insusceptibility to vancomycin and other glycopeptides in Staphylococcus aureus organisms that are virulent enough to cause infection in patients with normal host defenses. In addition, multidrug-resistant organisms like methicillin-resistant S.aureus are spreading from healthcare to community settings, and community organisms like Streptococcus pneumoniae are spreading to healthcare settings. Focal persistence and subsequent worldwide spread of enterococci resistant to vancomycin and other glycopeptides and multiple-resistance mechanisms in the same organism also require attention. Strategies such as multidisciplinary management of infections, appropriate infection control measures, and surveillance of resistance patterns are necessary to address the problem of resistance. Intensivists have been prominent in research and control efforts in this field and should continue to lead future efforts.

References

Feb 1, 1995·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J E McGowan
Jun 1, 1997·Infectious Disease Clinics of North America·J E McGowan, F C Tenover
Mar 21, 1998·Archives of Internal Medicine·V StosorG A Noskin
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R P Wenzel, M B Edmond
Oct 24, 1998·The Journal of Antimicrobial Chemotherapy·A P Fraise
May 29, 1999·The American Journal of Medicine·M R Jacobs
May 29, 1999·The American Journal of Medicine·T M Perl
Aug 17, 1999·Journal of Clinical Microbiology·F G O'BrienW B Grubb
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R N Greenberg, E Martin
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S K FridkinF C Tenover
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R C Moellering
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V Kak, D P Levine
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L JohnstonG Tyrrell
Dec 22, 1999·Emerging Infectious Diseases·G V DoernE Wingert
Dec 23, 1999·The Journal of Infectious Diseases·P DescheemaekerH Goossens
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A E FioreA Schuchat
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A I KoL W Riley
Feb 5, 2000·The Journal of Hospital Infection·F C Tenover
Feb 8, 2000·The Journal of Antimicrobial Chemotherapy·N WoodfordH M Aucken
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N SinghI R Marino
Mar 9, 2000·The Journal of Hospital Infection·M MorganA Howard
Mar 9, 2000·The New England Journal of Medicine·J P NuortiR F Breiman
Mar 9, 2000·The New England Journal of Medicine·B E Murray
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J M GarbuttL M Mundy
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J P MetlayR F Breiman
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Abi-HannaJ F Marcinak
Mar 30, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J KallenM R Wallace
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·S R Filipe, A Tomasz
Apr 15, 2000·Diagnostic Microbiology and Infectious Disease·S S WongK Y Yuen
May 16, 2000·Chest·S S Dhillon, C Watanakunakorn

❮ Previous
Next ❯

Citations

Oct 19, 2006·Journal of Microbiological Methods·L C ThomasJ Iredell
Nov 3, 2005·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Keishi MiwaToshiaki Ikeda
Apr 10, 2002·Critical Care Nursing Clinics of North America·Jaye S Weston
Oct 19, 2002·Current Opinion in Critical Care·Wolfgang A Krueger, Klaus E Unertl
Oct 21, 2005·Anaesthesia and Intensive Care·K L BuisingG V Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.